Polymerase News and Research

RSS
Asymptomatic SARS-CoV-2 infection among research personnel: Study

Asymptomatic SARS-CoV-2 infection among research personnel: Study

Researchers use mouse model to explore correlation of impaired interferon-mediated immune response with severe COVID-19

Researchers use mouse model to explore correlation of impaired interferon-mediated immune response with severe COVID-19

Study explores SARS-CoV-2 antibody responses in mild COVID-19 cases

Study explores SARS-CoV-2 antibody responses in mild COVID-19 cases

Durability and neutralization capacity of SARS-CoV-2 specific antibodies in the breastmilk of convalescent COVID-19 mothers

Durability and neutralization capacity of SARS-CoV-2 specific antibodies in the breastmilk of convalescent COVID-19 mothers

COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

Researchers develop new platform capable of mitochondrial DNA editing

Researchers develop new platform capable of mitochondrial DNA editing

Treating COVID-19 using monoclonal antibodies during pregnancy

Treating COVID-19 using monoclonal antibodies during pregnancy

Vaccine effectiveness against COVID-19 infection and related hospitalization

Vaccine effectiveness against COVID-19 infection and related hospitalization

Within-host model for the description of SARS-CoV-2 viral dynamics in the upper respiratory tract

Within-host model for the description of SARS-CoV-2 viral dynamics in the upper respiratory tract

The challenges of Omicron

The challenges of Omicron

Monoclonal-antibody combination AZD7442 prevents COVID-19

Monoclonal-antibody combination AZD7442 prevents COVID-19

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

Booster vaccine provides similar protection in SARS-CoV-2 naive and convalescent individuals

Booster vaccine provides similar protection in SARS-CoV-2 naive and convalescent individuals

4% patients with COVID-19 shed fecal viral RNA 10 months after diagnosis

4% patients with COVID-19 shed fecal viral RNA 10 months after diagnosis

Impact of COVID-19 vaccination on anti-nucleocapsid antibody levels

Impact of COVID-19 vaccination on anti-nucleocapsid antibody levels

How does SARS-CoV-2 infection affect the diversity of the gut microbiome?

How does SARS-CoV-2 infection affect the diversity of the gut microbiome?

Rhinovirus the main virus co-circulating with SARS-CoV-2 in children

Rhinovirus the main virus co-circulating with SARS-CoV-2 in children

COVID-19 mRNA vaccine protects against ICU admission for 1 year

COVID-19 mRNA vaccine protects against ICU admission for 1 year

CRISPR-based detection of SARS-CoV-2 RNA directly from patient swabs

CRISPR-based detection of SARS-CoV-2 RNA directly from patient swabs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.